Royalty Report: Medical, Device, cardiac – Collection: 259792

License Grant

To resolve all aspects of the present dispute, the Licensee entered into a settlement agreement with the Canadian Licensor. The settlement agreement contemplates certain fees being paid by the Licensee to the Licensor. In addition, following the first commercial sale of the Tiaraâ„¢, Licensee will pay a royalty on the annual net sales of the Tiara valve, a self-expanding mitral bioprosthesis for transcatheter implantation in patients with Mitral Regurgitation.

License Property

Licensors filed suit against the Licensee Parties –  relating to mitral valve, a self-expanding mitral bioprosthesis for transcatheter implantation in patients with Mitral Regurgitatione replacement and made, used or sold by utilizing or practicing Licensor Trade-Secrets.

Field of Use

Device used in mitral valve replacement.  The mitral valve is a valve that lets blood flow from one chamber of the heart, the left atrium, to another called the left ventricle.

License Grant

University hereby grants to each Canadian Licensee a worldwide non-exclusive, royalty-bearing right and license, with the right to sublicense, under the Penn Know-How to make, have made, use, distribute, sell, offer for sale, develop, promote, import, export and otherwise exploit Licensed Products in the Field of Use during the Term (the “License”).

License Property

Licensed Product means any Product relating to mitral valves and made, used or sold by utilizing or practicing Licensor Know-How,  including the “Tiara” transcatheter mitral valve product and any other next generation of “Tiara” product.  Tiaraâ„¢ is a minimally invasive transcatheter device for patients who experience severe mitral regurgitation utilizing the Licensor know-how.

“Licensed Product” means any Product (i) relating to mitral valves and (ii) made, used or sold by utilizing or practicing Penn Know-How.

Field of Use

The Licensee is a medical device company that specializes in developing, manufacturing, and marketing cardiovascular products including Tiara. Tiara is implanted in the heart using a minimally invasive, transapical transcatheter approach without the need for open-heart surgery or use of a cardiac bypass machine.

License Grant

The parties are adverse parties following currently pending litigation matters, which are being terminated pursuant to a Settlement Agreement.

The parties are engaged in, inter alia, the design, development, manufacture, and sale of CRM Products.

Pursuant to the Settlement Agreement, the parties have agreed to terminate certain cases and have agreed to enter into a cross licensing of certain rights under the Licensed Patents and Sublicensable Patents.

Licensor grants a non-exclusive, irrevocable, perpetual, worldwide license or sublicense, as the case may be, without the right to sublicense, under all Licensed Patents of Licensor to make, have made, use, sell, have sold, offer to sell, distribute, have distributed, and otherwise dispose of CRM Products, including supplying or causing to be supplied components thereof for use therein, and further including importing CRM Products, including components thereof for use therein, into any jurisdiction where Licensed Patents of Licensor are effective.

Licensor grants the right and option for a period of thirty (30) months from the Effective Date to obtain a non-exclusive, worldwide, non-transferable, royalty-bearing license under the CIC Patents.

License Property

CRM Products means devices for monitoring or electrically stimulating or shocking the heart which are suitable for chronic implantation, in whole or in part, by or with human patients. The term CRM Products includes, without limitation cardiac pacemakers, antitachycardia pacemakers, cardiac resynchronization therapy systems, cardioverters, and defibrillators, including combinations thereof; loop recording systems, implantable cardiac monitoring systems, implantable hemodynamic monitoring systems, pulse generators and other waveform generators for such devices; cardiac lead implant catheters and associated tools; leads, electrodes, sensors, capacitors, batteries, power sources, and all other components for such devices; mechanisms for coupling such generators in a stimulating, shocking, sensing, or monitoring relationship to the heart; and data dispensing, processing, and gathering systems for such devices, including programmers, pacing system analyzers, defibrillation system analyzers, testers, encoders, decoders, transtelephonic and other remote monitoring systems and services for use with implantable devices, transmitters, receivers, and computer software-controlled systems, and including the software.

Field of Use

The field of use is the pacemaker monitoring industry.

License Grant

The parties are adverse parties following currently pending litigation matters, which are being terminated pursuant to a Settlement Agreement.

The parties are engaged in, inter alia, the design, development, manufacture, and sale of CRM Products.

Pursuant to the Settlement Agreement, the parties have agreed to terminate certain cases and have agreed to enter into a cross licensing of certain rights under the Licensed Patents and Sublicensable Patents.

Licensor grants a non-exclusive, irrevocable, perpetual, worldwide license or sublicense, as the case may be, without the right to sublicense, under all Licensed Patents of Licensor to make, have made, use, sell, have sold, offer to sell, distribute, have distributed, and otherwise dispose of CRM Products, including supplying or causing to be supplied components thereof for use therein, and further including importing CRM Products, including components thereof for use therein, into any jurisdiction where Licensed Patents of Licensor are effective.

Licensor shall grant the right and option until the expiration of thirty (30) months from the Effective Date or ninety (90) days from the date Licensor exercises its option, whichever is later in time, to obtain a non-exclusive, worldwide, non-transferable, license under the specific Patents.

License Property

CRM Products means devices for monitoring or electrically stimulating or shocking the heart which are suitable for chronic implantation, in whole or in part, by or with human patients. The term CRM Products includes, without limitation cardiac pacemakers, antitachycardia pacemakers, cardiac resynchronization therapy systems, cardioverters, and defibrillators, including combinations thereof; loop recording systems, implantable cardiac monitoring systems, implantable hemodynamic monitoring systems, pulse generators and other waveform generators for such devices; cardiac lead implant catheters and associated tools; leads, electrodes, sensors, capacitors, batteries, power sources, and all other components for such devices; mechanisms for coupling such generators in a stimulating, shocking, sensing, or monitoring relationship to the heart; and data dispensing, processing, and gathering systems for such devices, including programmers, pacing system analyzers, defibrillation system analyzers, testers, encoders, decoders, transtelephonic and other remote monitoring systems and services for use with implantable devices, transmitters, receivers, and computer software-controlled systems, and including the software.

Field of Use

The field of use is the medical (pacemaker) industry.